Resources for Journalists

COVID-19 is a disease caused by the SARS-CoV-2 virus strain, that has not been previously identified in humans. See below for a collection of resources to help you cover this issue (Please note: additional resources are available to journalists who are logged in).

The AusSMC also issues a daily COVID-19 update for registered journalists (click here to view an example). If you would like to receive this email, please go to your profile on MyScimex and select yes beside "Receive COVID-19 Updates?". The email update and this resources page are supported by the Google News Initiative.

Latest COVID-19 news, research, expert reactions and briefings

Show/Hide newsfeed filter Filter by
Type
News for

Choose a location of interest

  1. Evidence of SARS-CoV-2 genetic material in the air

    Publicly released: Tue 28 Apr 2020 at 0800 AEST, 1000 NZST

    Nature

    Chinese researchers have found evidence that the genetic material of the virus behind COVID-19 can be airborne. ... The research team set up aerosol “traps” around two hospitals treating COVID-19 Read more about Evidence of SARS-CoV-2 genetic material in the air

    InternationalWuhan University, China
  2. Coronavirus: Animal disease detectives to be trained across SE Asia

    Publicly released: Mon 27 Apr 2020 at 1930 AEST, 2130 NZST

    Project work in 11 countries aims to prevent spread of zoonotic and animal diseases. Read more about Coronavirus: Animal disease detectives to be trained across SE Asia

    Australia; InternationalThe University of Sydney
  3. Medical students benefit from 'real-life' COVID-19 learnings

    Publicly released: Mon 27 Apr 2020 at 1400 AEST, 1600 NZST

    Medical Journal of Australia

    Despite some disruption, medical students have benefited from witnessing the health systems approach to the COVID-19 pandemic and have demonstrated their commitment to health care and their chosen Read more about Medical students benefit from 'real-life' COVID-19 learnings

    Australia; SA; NTFlinders University
  4. EXPERT REACTION: COVIDSafe app released, but does it work on iPhones?

    Publicly released: Mon 27 Apr 2020 at 1400 AEST, 1600 NZST

    The Federal Government has released the COVIDSafe app to help fight COVID19 but there is still confusion about whether the tracking app works in the background on iPhones. Read more about EXPERT REACTION: COVIDSafe app released, but does it work on iPhones?

    Australia; NSW; WAThe University of New South Wales | The University of Western Australia ...
  5. Leg up for podiatry students as 3D-printed feet put them strides ahead of the rest

    Publicly released: Mon 27 Apr 2020 at 1230 AEST, 1430 NZST

    3D-printed feet – complete with calluses, corns and fake toenails – will enable UniSA’s podiatry students to practise and fine-tune their podiatry skills from the comfort of their own home, Read more about Leg up for podiatry students as 3D-printed feet put them strides ahead of the rest

    Australia; SAUniversity of South Australia
  6. Can DIY facemasks and 3D printed parts help fight COVID-19?

    Publicly released: Sat 25 Apr 2020 at 0400 AEST, 0600 NZST

    PLOS Biology

    Free open-source hardware and 3D printing could help to alleviate the burden of COVID-19 on global health systems, according to UK research. ... The researchers found that although some of the designs Read more about Can DIY facemasks and 3D printed parts help fight COVID-19?

    InternationalUniversity of Sussex, UK
  7. Small trial of Trump's 'miracle' COVID-19 drug chloroquine suggests high doses are dangerous

    Publicly released: Sat 25 Apr 2020 at 0105 AEST, 0305 NZST

    JAMA Network Open

    Brazilian and Spanish scientists conducted a small trial of two different doses of much touted 'miracle' drug chloroquine in 81 patients hospitalised with COVID-19 to invesitage safety and efficacy. Read more about Small trial of Trump's 'miracle' COVID-19 drug chloroquine suggests high doses are dangerous

    InternationalFundação de Medicina Tropical Dr Heitor Vieira Dourado, Brazil
  8. COVID-19: New model predicts its course, resolution and eventual good news

    Publicly released: Fri 24 Apr 2020 at 1201 AEST, 1401 NZST

    The team led by Professor Dan Nicolau, predict the trajectory of the virus and its mortality, based on reliable, country-independent data. ... Figures are updated daily and show the world is in the middle Read more about COVID-19: New model predicts its course, resolution and eventual good news

    Australia; QLDQueensland University of Technology (QUT)
  9. Saliva may be more sensitive for SARS-CoV-2 detection than invasive swabs

    Publicly released: Fri 24 Apr 2020 at 1200 AEST, 1400 NZST

    Rapid and accurate testing is essential for controlling the ongoing COVID-19 pandemic. ... The current gold standard for COVID-19 diagnosis uses nasopharyngeal swabs. A new pre-print study, which has not Read more about Saliva may be more sensitive for SARS-CoV-2 detection than invasive swabs

    New Zealand; InternationalYale School of Public Health, USA
  10. Pharmacists step up in fight against COVID-19

    Publicly released: Fri 24 Apr 2020 at 1130 AEST, 1330 NZST

    Staff and students from The University of Queensland School of Pharmacy have stepped up to ease the pressure on the health workforce during the COVID-19 pandemic. Read more about Pharmacists step up in fight against COVID-19

    Australia; QLDThe University of Queensland
  11. COVID-19: infected Aussie healthcare workers usually get it away from work

    Publicly released: Fri 24 Apr 2020 at 1100 AEST, 1300 NZST

    MJA

    It's pretty uncommon for a healthcare worker to have COVID-19, say Aussie researchers in a preprint letter, though those that do contract it usually do so outside of their ... They say that over the past Read more about COVID-19: infected Aussie healthcare workers usually get it away from work

    Australia; VICThe University of Melbourne
  12. Nose cells are coronavirus hotspot

    Publicly released: Fri 24 Apr 2020 at 1100 AEST, 1300 NZST

    Nature Medicine

    Nasal swabs have been found to have far higher concentrations of the SARS-CoV-2 virus than throat swabs, and British researchers have made a step towards finding out why. ... The researchers say it Read more about Nose cells are coronavirus hotspot

    Australia; International; NSWGarvan Institute of Medical Research | The University of New South Wales ...
  13. COVID-19 research funding for NZ

    Publicly released: Fri 24 Apr 2020 at 1053 AEST, 1253 NZST

    COVID-19 research projects funded by the Auckland Medical Research Foundation are due to look into the wellbeing of frontline nurses, the mental health effects of lockdown particularly on young Read more about COVID-19 research funding for NZ

    New ZealandAuckland Medical Research Foundation
  14. Is it wrong to prioritise younger patients with COVID-19?

    Publicly released: Fri 24 Apr 2020 at 1030 AEST, 1230 NZST

    The BMJ

    Two experts go head-to-head on one of the toughest ethical topics arising from this pandemic - how to prioritise scarce intensive care resources. ... One professor argues that it’s hard to know where to Read more about Is it wrong to prioritise younger patients with COVID-19?

    InternationalQueen's University, UK
  15. Lack of PPE is causing Australian frontline healthcare workers to question their willingness to work

    Publicly released: Fri 24 Apr 2020 at 1030 AEST, 1230 NZST

    Research led by Edith Cowan University has confirmed that difficulty accessing personal protective equipment (PPE) is forcing healthcare workers on the frontline to question their willingness to work Read more about Lack of PPE is causing Australian frontline healthcare workers to question their willingness to work

    Australia; WAEdith Cowan University
  16. HIV and flu drugs show 'little benefit' for mild/moderate COVID-19 cases

    Publicly released: Fri 24 Apr 2020 at 0932 AEST, 1132 NZST

    Med

    Chinese researchers have assessed patients with mild-to-moderate cases of COVID-19, randomly assigning 34 to receive the HIV drug lopinavir/ritonavir, 35 to the influenza drug Arbidol, and 17 Read more about HIV and flu drugs show 'little benefit' for mild/moderate COVID-19 cases

    InternationalGuangzhou Medical University, China
  17. Highlighting diabetes risks in COVID-19

    Publicly released: Fri 24 Apr 2020 at 0830 AEST, 1030 NZST

    The Lancet Diabetes & Endocrinology

    An international review involving Monash University has found elderly people with diabetes who contract COVID-19 are at a much higher risk of dying from the disease - and the virus may ... The study, Read more about Highlighting diabetes risks in COVID-19

    Australia; VICMonash University
  18. ‘DIY’ technique to ventilate two patients with one machine

    Publicly released: Fri 24 Apr 2020 at 0830 AEST, 1030 NZST

    Thorax

    They say this 'extreme' technique could be used should doctors face severe equipment shortages in the COVID-19 pandemic, but recognise the most difficult choice during such an emergency would be Read more about ‘DIY’ technique to ventilate two patients with one machine

    InternationalUniversity of Bologna, Italy
  19. BRIEFING: How NZ moved during lockdown

    Publicly released: Fri 24 Apr 2020 at 0300 AEST, 0500 NZST

    As part of the SMC's COVID-19 response, we are funding data visualisations that are available to media under creative commons. ... The data also modelled the population counts to take into consideration Read more about BRIEFING: How NZ moved during lockdown

    New ZealandScience Media Centre (New Zealand)
  20. NZ scientists seek support to develop COVID-19 therapies

    Publicly released: Thu 23 Apr 2020 at 2201 AEST, Fri 24 Apr 20 at 0001 NZST

    New Zealand Medical Journal

    While the world waits for a viable vaccine, a group of New Zealand scientists have outlined the need to develop effective treatments for COVID-19. ... The scientists argue that work to develop these Read more about NZ scientists seek support to develop COVID-19 therapies

    New ZealandUniversity of Otago

Show Results

  1. 10
  2. 20
  3. 50